Alivus Life Sciences Ltd.

NSE: ALIVUS | BSE: 543322 | ISIN: INE03Q201024 | Industry: Pharmaceuticals
| Expensive Performer
1100.6000 -32.80 (-2.89%)
NSE Mar 21, 2025 15:31 PM
Volume: 47,709
 

logo
Alivus Life Sciences Ltd.
16 Jul 2024
1100.60
-2.89%
buy
by Hem Securities
Target: 987 | Target met
Hem Securities
 
Alivus Life Sciences Ltd. has gained 46.70% in the last 1 Year
More from Alivus Life Sciences Ltd.
Recommended
Five Interesting Stocks Today - March 21, 2025
The Baseline | 21 Mar 2025, 05:17PM
Market closes higher, CBI arrests Power Grid Corp's General Manager and KEC Intl's Deputy General Manager
Trendlyne Marketwatch | 21 Mar 2025, 04:10PM
Glenmark Life Sciences: The hived off API business of Glenmark Pharma goes public
| 27 Jul 2021